Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. reports developments in AI-powered digital investigative and intelligence software for public and private sector customers. Its updates cover digital forensics, lawful device access, evidence analysis, investigative collaboration, application security and cloud deployment, including Cellebrite Government Cloud, Guardian Investigate, Genesis and Corellium.
Company news also includes federal cloud-security authorization, product releases, financial results, annual reporting, investor conference participation and product and technology leadership changes. Cellebrite’s software portfolio supports law enforcement agencies, defense and intelligence organizations, enterprises and service providers across cloud, on-premises and hybrid deployments.
Cellebrite (NASDAQ: CLBT) appointed Shiven Ramji as Chief Executive Officer, succeeding Thomas E. Hogan in a planned transition effective immediately. Ramji, who joined as President, Products and Technology in May 2026, will also join the Board of Directors.
For Q2 2026, Cellebrite reported ARR of $507.8 million (up 21% year-over-year) and revenue of $131.1 million (up 16% year-over-year). Subscription revenue reached $119.5 million, also up 16%. GAAP net income was $6.4 million and non-GAAP net income was $29.7 million. Adjusted EBITDA was $31.8 million with a 24.2% margin, and trailing twelve-month free cash flow was $144.2 million (28.0% margin).
The company cited longer sales cycles and lower-than-expected Inseyets expansions, leading to lowered full-year 2026 ARR and revenue outlook, now targeting ARR of $550–$560 million and revenue of $555–$561 million. At the same time, Cellebrite raised its 2026 adjusted EBITDA target to $153–$159 million (around 28% margin), reflecting continued operating discipline.
Cellebrite (NASDAQ: CLBT) will release its second-quarter 2026 financial results before U.S. markets open on Thursday, August 13, 2026, and will host a live conference call and webcast at 8:30 a.m. ET to review results and discuss its 2026 outlook. Access details, including call-in numbers, conference ID CLBTQ226, and webcast links, are provided, with historical financial tables and supplemental data to be posted on the company’s investor relations website.
Cellebrite (Nasdaq: CLBT) expanded its exclusive partnership with SkySafe to unify drone detection, airspace intelligence and digital forensics in a single investigative workflow.
The agreement makes Cellebrite SkySafe’s exclusive digital forensics partner, integrating real-time and historical UAV flight data with mobile evidence to deliver richer, actionable intelligence for public safety, defense and enterprise investigations.
Cellebrite (Nasdaq: CLBT) announced general availability of Cellebrite Genesis, an AI-powered digital investigation platform designed to analyze growing volumes of digital evidence in minutes instead of days or weeks.
Genesis supports 35+ evidence formats, has guardrails for data privacy, and was tested in Early Access by over 800 users across 300 agencies.
Cellebrite (NASDAQ: CLBT) will host two investor events on June 10, 2026. The Cellebrite AI Technology Talk, a webcast deep dive into its AI, including the new Genesis investigative platform, starts at 9:00 a.m. ET, followed by a fireside chat at the Mizuho Technology Conference 2026 at 11:15 a.m. ET.
Cellebrite (NASDAQ: CLBT) reported first-quarter 2026 revenue of $128.3 million, up 19% year-over-year, with subscription revenue of $117.9 million, up 23%. ARR reached $493 million, up 21%, and trailing 12‑month free cash flow was $158.6 million, a 32% margin.
GAAP net income was $10.9 million (EPS $0.04) and non-GAAP net income $30.6 million (EPS $0.12). The company closed its acquisition of SCG Canada, launched new AI-driven products, and guided 2026 ARR to $567–$573 million and revenue to $565–$571 million.
Cellebrite (NASDAQ: CLBT) announced management will participate in investor conferences in May–June 2026, including J.P. Morgan (May 18), TD Cowen (May 27), Craig-Hallum (May 28), William Blair (June 3), Mizuho (June 10) and D.A. Davidson (June 11).
Executives presenting include CEO Thomas Hogan and CFO David Barter; many sessions are fireside chats or 1x1 meetings and webcasts are available on the investor events page.
Cellebrite (Nasdaq: CLBT) announced that Cellebrite Government Cloud achieved FedRAMP High Authorization on May 6, 2026, with the U.S. Department of Justice as the authorizing agency.
The designation lists CGC on the FedRAMP Marketplace, enables DOJ component reuse and accelerates ATOs for other federal agencies, and covers Cellebrite Inseyets and Cellebrite Guardian for secure cloud-based digital forensics and evidence management.
Cellebrite (Nasdaq: CLBT) appointed Shiven Ramji as President, Products and Technology, effective May 4, 2026. Ramji will lead product and technology, succeeding Ronnen Armon, who will retire after a transition period. Ramji joins from Okta/Auth0, where he managed a $1 billion ARR business and held senior product roles at multiple tech firms.
The company said Ramji will drive AI adoption across Cellebrite's Digital Investigative and Intelligence platform and broaden product offerings to support customers.
Cellebrite (NASDAQ: CLBT) will report first-quarter 2026 financial results before U.S. markets open on Thursday, May 14, 2026.
The company will host a live conference call and webcast at 8:30 a.m. ET the same morning. Historical financial tables and supplemental data will be posted to the quarterly results section of the investor relations website.
Call details include conference ID CLBTQ126 and live webcast links for investors.